11 series
Export
<<<Page of 1 >>>
Accession Title Series type(s) Organism(s) Samples GDS Supplementary Contact Release date
Remove filtersFilter Remove filterCeratonia siliqua Remove filterJeff Gildersleeve
GSE99872
Therapeutic antibodies to ganglioside GD2 evolved from highly selective germline antibodies I
6 Jeff Gildersleeve Aug 25, 2017
GSE99873
Therapeutic antibodies to ganglioside GD2 evolved from highly selective germline antibodies II
14 Jeff Gildersleeve Aug 25, 2017
GSE99874
Therapeutic antibodies to ganglioside GD2 evolved from highly selective germline antibodies III
7 Jeff Gildersleeve Aug 25, 2017
GSE100307
Therapeutic antibodies to ganglioside GD2 evolved from highly selective germline antibodies IV
7 Jeff Gildersleeve Aug 25, 2017
GSE100308
Therapeutic antibodies to ganglioside GD2 evolved from highly selective germline antibodies V
7 Jeff Gildersleeve Aug 25, 2017
GSE100309
Therapeutic antibodies to ganglioside GD2 evolved from highly selective germline antibodies VI
7 Jeff Gildersleeve Aug 25, 2017
GSE100310
Therapeutic antibodies to ganglioside GD2 evolved from highly selective germline antibodies VII
7 Jeff Gildersleeve Aug 25, 2017
GSE100438
Therapeutic antibodies to ganglioside GD2 evolved from highly selective germline antibodies
55 Jeff Gildersleeve Aug 25, 2017
GSE83087
Whole-Cell Cancer Vaccines Induce Large Antibody Responses to Carbohydrates and Glycoproteins
168 Jeff Gildersleeve Dec 13, 2016
GSE68403
Development of a glycan microarray based method for ABO blood typing
220 Jeff Gildersleeve Apr 28, 2016
GSE68405
A Simple, Inexpensive Strategy for Predicting Potential Beneficial Clinical Responses on Prostate Cancer Vaccine Therapy
331 Jeff Gildersleeve Apr 28, 2016